One paper evaluated the in vitro synthesis of the anti-inflammatory cytokine IL-12, reporting that it is increased by the treatment of 4T1 mouse breast cancer cells with endothelin-1 [47]. This evidence concerns the gene EDN1 and breast carcinoma.